In today's interconnected world, infectious diseases pose an escalating threat, as demonstrated by the coronavirus pandemic ...
This development comes at a time when pharmaceutical firms are discontinuing discovery efforts in next-generation COVID-19 ...
Infectious diseases are becoming more frequent, more severe, and harder to control in our closely connected world. Viruses ...
Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral ...
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.
Four antiviral drugs are available for the prevention and treatment of influenza infections: oseltamivir, zanamivir, rimantadine and amantadine. Oseltamivir and zanamivir are neuraminidase ...
We didn’t start Model to launch a company—we started it because no one else met our standards,” says Dr. Daniel Haders II, CEO and founder of Model Medicines. On this episode of Vanguards of Health ...
Existing flu antivirals may not work well against H5N1; avoiding raw milk and reducing dairy worker exposure may be the best ways to prevent infection. Scientists found that frequently used flu ...
Hepatitis B is a liver infection cause by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer than six months are considered “chronic”. Chronic hepatitis B (CHB) poses a ...
Ever since being established in 1658, the Royal Life Guards have stood watch at Amalienborg Palace in Copenhagen, guarding the king and queen. The changing of the guards has become a tourist ...
Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...